Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials

Although the understanding of secondary progressive multiple sclerosis (SPMS) is evolving, early detection of relapse-independent progression remains difficult. This is further complicated by superimposed relapses and compensatory mechanisms that allow for silent progression. The term relapsing mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayas, Antonios, Christ, Monika, Faissner, Simon, Klehmet, Juliane, Pul, Refik, Skripuletz, Thomas, Meuth, Sven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880589/
https://www.ncbi.nlm.nih.gov/pubmed/36710720
http://dx.doi.org/10.1177/17562864221146836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880589/
https://www.ncbi.nlm.nih.gov/pubmed/36710720
http://dx.doi.org/10.1177/17562864221146836

Ejemplares similares